The biotechnology mini portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The biotechnology mini portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	7/20/2006 11:38:34 AM
	Read Replies (1) of 93

the view of ARNA, for me..... a very different view than most take, which pisses me off no end...... oral bioavailability JNJ, T2D, two molecules approximately one fourth of potential profit phase I trial for 1st molecule launched 2/06 Message 21395498 (randomized, double-blind, placebo-controlled phase II Merck clinical trial launched 5/06) cash, property, clinical and preclinical pipe (three projects, no partner), platform, burn, MC:cash < 2 (non-dilute), price:book < 2.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next